218 related articles for article (PubMed ID: 22004611)
1. Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems.
Sugimoto Y; Yamamoto M; Tagawa N; Kobayashi Y; Mitsui-Saitoh K; Hotta Y; Yamada J
Eur J Pharmacol; 2011 Dec; 672(1-3):121-5. PubMed ID: 22004611
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the 5-HT(1A) receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT(1A) receptor binding.
Sugimoto Y; Furutani S; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
Eur J Pharmacol; 2010 Mar; 629(1-3):53-7. PubMed ID: 19958758
[TBL] [Abstract][Full Text] [Related]
3. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine.
Sugimoto Y; Tagawa N; Kobayashi Y; Mitsui-Saito K; Hotta Y; Yamada J
Eur J Pharmacol; 2012 Dec; 696(1-3):96-100. PubMed ID: 23041149
[TBL] [Abstract][Full Text] [Related]
5. Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of urocortin 3 in a modified forced swimming test in mice.
Tanaka M; Telegdy G
Brain Res Bull; 2008 Nov; 77(5):301-5. PubMed ID: 18793704
[TBL] [Abstract][Full Text] [Related]
6. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Yi LT; Xu HL; Feng J; Zhan X; Zhou LP; Cui CC
Physiol Behav; 2011 Jan; 102(1):1-6. PubMed ID: 20951716
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effects of neferine in the forced swimming test involve the serotonin1A (5-HT1A) receptor in mice.
Sugimoto Y; Furutani S; Nishimura K; Itoh A; Tanahashi T; Nakajima H; Oshiro H; Sun S; Yamada J
Eur J Pharmacol; 2010 May; 634(1-3):62-7. PubMed ID: 20176013
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.
Gay BM; Prigol M; Stein AL; Nogueira CW
Neuropharmacology; 2010 Sep; 59(3):172-9. PubMed ID: 20488195
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems.
Capra JC; Cunha MP; Machado DG; Zomkowski AD; Mendes BG; Santos AR; Pizzolatti MG; Rodrigues AL
Eur J Pharmacol; 2010 Sep; 643(2-3):232-8. PubMed ID: 20599906
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
[TBL] [Abstract][Full Text] [Related]
11. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
Hirano S; Miyata S; Onodera K; Kamei J
Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effect of bis-eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system.
do Amaral JF; Silva MI; de Aquino Neto MR; Moura BA; de Carvalho AM; Vasconcelos PF; Barbosa Filho JM; Gutierrez SJ; Vasconcelos SM; Macêdo DS; de Sousa FC
Fundam Clin Pharmacol; 2013 Oct; 27(5):471-82. PubMed ID: 22827775
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system.
Posser T; Kaster MP; Baraúna SC; Rocha JB; Rodrigues AL; Leal RB
Eur J Pharmacol; 2009 Jan; 602(1):85-91. PubMed ID: 19026628
[TBL] [Abstract][Full Text] [Related]
14. Chronopharmacological study of antidepressants in forced swimming test of mice.
Ushijima K; Sakaguchi H; Sato Y; To H; Koyanagi S; Higuchi S; Ohdo S
J Pharmacol Exp Ther; 2005 Nov; 315(2):764-70. PubMed ID: 16079297
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716
[TBL] [Abstract][Full Text] [Related]
16. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
Wang R; Xu Y; Wu HL; Li YB; Li YH; Guo JB; Li XJ
Eur J Pharmacol; 2008 Jan; 578(1):43-50. PubMed ID: 17942093
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium.
Cardoso CC; Lobato KR; Binfaré RW; Ferreira PK; Rosa AO; Santos AR; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):235-42. PubMed ID: 19059299
[TBL] [Abstract][Full Text] [Related]
18. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
Redrobe JP; Bourin M; Colombel MC; Baker GB
J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
[TBL] [Abstract][Full Text] [Related]
19. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
Freitas AE; Budni J; Lobato KR; Binfaré RW; Machado DG; Jacinto J; Veronezi PO; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):335-43. PubMed ID: 20026371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
